Corporate News 23-May-24
Piramal Pharma's Lexington facility completes USFDA inspection
Piramal Pharma announced that US FDA has issued an Establishment Inspection Report (EIR) for the its manufacturing facility located at Lexington, USA and the inspection has now been successfully closed by the US FDA.
Previous News
Piramal Pharma forays into men's grooming market in India with launch of BOHEM
( Corporate News - 10-Apr-24 16:54 )
Piramal Pharma reports standalone net profit of Rs 74.34 crore in the December 2023 quarter
( Results - Announcements 31-Jan-24 07:43 )
Piramal Pharma slumps after dismal Q3 results
( Hot Pursuit - 09-Feb-23 14:46 )
Board of Piramal Pharma recommends final dividend
( Corporate News - 11-May-24 09:40 )
Piramal Pharma Q1 net loss narrows to Rs 98 cr
( Hot Pursuit - 04-Aug-23 11:18 )
Piramal Pharma gains after successful completion of US FDA inspection at Pithampur facility
( Hot Pursuit - 22-May-23 10:58 )
Piramal Pharma gains as Q4 PAT doubles to Rs 101 crore
( Hot Pursuit - 13-May-24 16:37 )
Piramal Pharma to conduct board meeting
( Corporate News - 29-Jul-23 17:22 )
Volumes spurt at Piramal Pharma Ltd counter
( Hot Pursuit - 05-Mar-24 11:00 )
Board of Piramal Pharma approves grant of 91.80 lakh stock options under
( Corporate News - 31-Jul-23 18:44 )
Piramal Pharma grants 48.30 lakh stock options
( Corporate News - 26-Jul-24 10:05 )
Other Stories
Gujarat Inject (Kerala) declare Quarterly Result
07-Oct-24 17:27
eMudhra to table results
07-Oct-24 17:27
Morarka Finance declare Quarterly Result
07-Oct-24 17:26
Board of India Infrastructure Trust recommends final dividend
07-Oct-24 17:26
Dhanlaxmi Bank to hold board meeting
07-Oct-24 17:26
MIC Electronics to hold board meeting
07-Oct-24 17:26
LTIMindtree declare Quarterly Result
07-Oct-24 17:26
Kesar Petroproducts to conduct board meeting
07-Oct-24 17:25
Bharat Electronics declare Quarterly Result
07-Oct-24 17:25
Daulat Securities to conduct board meeting
07-Oct-24 17:25
Back
Top
